Interpreting Within-Patient Changes on the EORTC QLQ-C30 and EORTC QLQ-LC13

被引:7
|
作者
Coon, Cheryl D. [1 ]
Schlichting, Michael [2 ]
Zhang, Xinke [3 ]
机构
[1] Outcometrix, Salida, CO 81201 USA
[2] Merck Healthcare KGaA, Darmstadt, Germany
[3] Merck KGaA, EMD Serono Res & Dev Inst Inc, Billerica, MA USA
来源
关键词
QUALITY-OF-LIFE; MINIMAL IMPORTANT DIFFERENCES; CLINICAL-TRIALS; REPORTED OUTCOMES; SCORES;
D O I
10.1007/s40271-022-00584-w
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Introduction When determining if changes on patient-reported outcome (PRO) scores in clinical trials convey a meaningful treatment benefit, statistical significance tests alone may not communicate the patient perspective. Appraising within-patient changes on PRO scores against established thresholds can determine if improvements or deteriorations experienced by individuals are meaningful. To evaluate the appropriateness of thresholds for interpreting meaningful improvements and deterioration within individuals on the European Organisation for Research and Treatment of Cancer (EORTC) 30-item core instrument (QLQ-C30) and 13-item lung cancer module (QLQ-LC13), a series of psychometric methods were applied to data from a phase III randomized controlled clinical trial in non-small cell lung cancer. Methods Anchor-based methods of empirical cumulative distribution functions and classification statistics were employed using change scores from Baseline to Week 7 using changes on the QLQ-C30 Global Health Status item as an anchor. Distribution-based methods of one-half standard deviation and standard error of measurement identified the minimum amount of change each domain score can reliably measure. Results While the correlations between the domain scores and the anchor item were modest in size (i.e., r >= 0.30 for only 5 of 24 domains), consideration of multiple methods along with the magnitude of possible step changes on the score allowed for patterns to emerge. The triangulation process planned a priori resulted in different methods being the source for different domain scores. Absolute values of the proposed thresholds ranged from 11.11 to 33.33, and all resulted in the same classifications for all EORTC domains, except QLQ-C30 Fatigue, as would the 10-point threshold that is traditionally used. Conclusion This study confirms the appropriateness of the 10-point EORTC score threshold generally used by the field for interpreting within-patient changes, but the thresholds proposed from this study enhance interpretability by corresponding to only observable locations along the domain score scale.
引用
收藏
页码:691 / 702
页数:12
相关论文
共 50 条
  • [1] Interpreting Within-Patient Changes on the EORTC QLQ-C30 and EORTC QLQ-LC13
    Cheryl D. Coon
    Michael Schlichting
    Xinke Zhang
    [J]. The Patient - Patient-Centered Outcomes Research, 2022, 15 : 691 - 702
  • [2] Quality of life of lung cancer patients: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13
    Wei-Chu Chie
    Chih-Hsin Yang
    Chiun Hsu
    Pan-Chyr Yang
    [J]. Quality of Life Research, 2004, 13 : 257 - 262
  • [3] Quality of life of lung cancer patients: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13
    Chie, WC
    Yang, CH
    Hsu, C
    Yang, PC
    [J]. QUALITY OF LIFE RESEARCH, 2004, 13 (01) : 257 - 262
  • [4] Quality of life research within the EORTC - the EORTC QLQ-C30
    Fayers, P
    Bottomley, A
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 : S125 - S133
  • [5] FACTORS AFFECTING THE HEALTH-RELATED QUALITY OF LIFE IN LUNG CANCER PATIENTS: MEASURED BY EORTC QLQ-C30 QLQ-LC13
    程晓麟
    迟金为
    周德明
    [J]. Chinese Journal of Cancer Research, 2003, (04) : 53 - 62
  • [6] THE EORTC QLQ-LC13 - A MODULAR SUPPLEMENT TO THE EORTC CORE QUALITY-OF-LIFE QUESTIONNAIRE (QLQ-C30) FOR USE IN LUNG-CANCER CLINICAL-TRIALS
    BERGMAN, B
    AARONSON, NK
    AHMEDZAI, S
    KAASA, S
    SULLIVAN, M
    [J]. EUROPEAN JOURNAL OF CANCER, 1994, 30A (05) : 635 - 642
  • [7] The Portuguese version of the EORTC QLQ-C30
    Ferreira, P
    [J]. 10TH INTERNATIONAL MEETING OF GYNAECOLOGICAL ONCOLOGY, 1997, : 527 - 532
  • [8] Estimation of meaningful change thresholds for the EORTC QLQ-C30 and QLQ-LC13 in patients with non-small cell lung cancer (NSCLC)
    Beaumont, Jennifer
    Yu, Hailin
    Lin, Huamao M.
    Goodman, Erin
    Hecht, Shoshana
    Le, Kimberly
    Romero, Heather
    Hudgens, Stacie
    [J]. QUALITY OF LIFE RESEARCH, 2021, 30 (SUPPL 1) : S101 - S101
  • [9] CROSS-CULTURAL APPLICATION OF THE EORTC QLQ-C30 AND QLQ-LC13: IMPACT OF SOCIAL EPIDEMIOLOGIC FACTORS ON QUALITY OF LIFE IN LUNG CANCER PATIENTS
    Ataman, F.
    Songur, N.
    Ay, S.
    Kaya, S.
    Bottomley, A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S279 - S279
  • [10] Psychometric properties of the EORTC QLQ-C30 in Uganda
    Naamala, Allen
    Eriksson, Lars E.
    Orem, Jackson
    Nalwadda, Gorrette K.
    Kabir, Zarina Nahar
    Wettergren, Lena
    [J]. HEALTH AND QUALITY OF LIFE OUTCOMES, 2021, 19 (01)